Utama › Hemofilia
Kajian klinikal Hemofilia sedang mengambil peserta di AS
28 kajian untuk Hemofilia sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Indianapolis, IN9 kajian
- Los Angeles, CA7 kajian
- Seattle, WA6 kajian
- Cedar Rapids, IA6 kajian
- Philadelphia, PA5 kajian
- Tampa, FL4 kajian
- Sacramento, CA4 kajian
- Atlanta, GA4 kajian
- Little Rock, AR4 kajian
- Dallas, TX4 kajian
- Greenville, NC4 kajian
- Orange, CA4 kajian
- San Francisco, CA3 kajian
- San Antonio, TX3 kajian
- St. Louis, MO3 kajian
- Detroit, MI3 kajian
- Chicago, IL3 kajian
- Boston, MA3 kajian
- Cincinnati, OH3 kajian
- Harrisburg, PA3 kajian
- Kansas City, MO3 kajian
- Aurora, CO3 kajian
Mengikut negeri
- Arkansas4 kajian
- California14 kajian
- Colorado3 kajian
- Florida6 kajian
- Georgia4 kajian
- Illinois4 kajian
- Indiana9 kajian
- Iowa6 kajian
- Massachusetts3 kajian
- Michigan5 kajian
- Missouri5 kajian
- New York4 kajian
- North Carolina6 kajian
- Ohio5 kajian
- Pennsylvania6 kajian
- Texas8 kajian
- Washington6 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT05568719TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Mengambil pesertaKajian pemerhatian
6 Months · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07692217Treatment of Hemophilia A Patients With FVIII Inhibitors
Mengambil pesertaKajian pemerhatian
Semua umur · Lelaki · Dikemas kini 23 Sep 2026 · NCT04023019A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07416526A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Mengambil pesertaFasa 3
Umur 1 hingga 17 · Lelaki · Dikemas kini 23 Sep 2026 · NCT05611801A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Mengambil pesertaFasa 4
Umur 12 ke atas · Lelaki · Dikemas kini 23 Sep 2026 · NCT06145373A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Lelaki · Dikemas kini 18 Sep 2026 · NCT07220564A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Mengambil pesertaFasa 1/2
Umur 2 hingga 59 · Lelaki · Dikemas kini 11 Sep 2026 · NCT05987449A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 11 Sep 2026 · NCT07226206A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07416604SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Mengambil pesertaFasa 3
Umur 6 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT04563520Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 0 hingga 20 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Mengambil pesertaFasa 3
Umur 1 hingga 11 · Lelaki · Dikemas kini 17 Ogo 2026 · NCT07285460Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Mengambil pesertaKajian pemerhatian
Umur 6 hingga 19 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Mengambil pesertaFasa 3
Umur 1 hingga 74 · Lelaki · Dikemas kini 1 Jul 2026 · NCT05145127A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Mengambil pesertaFasa 1
Umur 12 hingga 74 · Lelaki · Dikemas kini 3 Jun 2026 · NCT06703606Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 2 Jun 2026 · NCT03695978Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Mengambil pesertaFasa 4
Umur 12 ke atas · Wanita · Dikemas kini 12 Mei 2026 · NCT05936580Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Mengambil pesertaFasa 4
Umur 12 ke atas · Lelaki · Dikemas kini 12 Mei 2026 · NCT05935358ATHNdataset Registry
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 21 Apr 2026 · NCT06820515Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Mengambil pesertaFasa 1
Umur 0 hingga 90 · Semua jantina · Dikemas kini 3 Apr 2026 · NCT05500807Hemophilia A Research Program
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Semua jantina · Dikemas kini 17 Feb 2026 · NCT07414511SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Mengambil pesertaFasa 4
Umur 12 hingga 100 · Semua jantina · Dikemas kini 12 Jan 2026 · NCT04647227Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.